NCT05543369View on ClinicalTrials.gov

Study to Compare the Level of Elafibranor in Blood After Repeat Administration in Japanese and Non-Asian Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

March 10, 2023

Study Completion Date

March 10, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

Elafibranor

Oral Tablet

Trial Locations (2)

90720

Collaborative Neuroscience Research, LLC, Los Alamitos

90806

Collaborative Neuroscience Research LLC, Long Beach

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY